ROYCE & ASSOCIATES LP

Position in HROW — Harrow, Inc.

CIK 906304 New York, NY

Position in HROW

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$6,565,309

+$5,165,029 QoQ

Shares Held

154,587

+289.3% QoQ

Ownership

0.412%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#26

of 221 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ROYCE & ASSOCIATES LP holds $49,989,480 across 12 Drug Manufacturers - Specialty & Generic names. HROW ranks #3 (13.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	COLL	Collegium Pharmaceutical, Inc	332,065	$12,020,753
2	TKNO	Alpha Teknova, Inc.	1,661,395	$9,436,723
3	HROW	Harrow, Inc. This page	154,587	$6,565,309
4	AMPH	Amphastar Pharmaceuticals, Inc.	294,758	$5,948,216
5	XERS	Xeris Biopharma Holdings, Inc.	461,153	$3,652,331
6	ALKS	Alkermes plc.	58,072	$3,042,972
7	ALVO	Alvotech	558,144	$2,059,551
8	SIGA	Siga Technologies Inc	551,010	$2,005,676

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,565,309	154,587	+289.3%	Shares	Sole	2026-08-14
2026-03-31	$1,400,280	39,713	-92.2%	Shares	Sole	2026-05-12
2025-12-31	$24,977,554	509,746	-4.4%	Shares	Sole	2026-02-09
2025-09-30	$25,680,566	533,013	-3.7%	Shares	Sole	2025-11-12
2025-06-30	$16,909,784	553,693	+69.3%	Shares	Sole	2025-08-11
2025-03-31	$8,700,753	327,096	+12.0%	Shares	Sole	2025-05-06
2024-12-31	$9,799,619	292,090	-18.9%	Shares	Sole	2025-02-10
2024-09-30	$16,199,987	360,320	-33.3%	Shares	Sole	2024-11-06
2024-06-30	$11,278,511	539,900	+71.5%	Shares	Sole	2024-08-13
2024-03-31	$4,166,127	314,900	+6.8%	Shares	Sole	2024-05-13
2023-12-31	$3,302,880	294,900	+1.7%	Shares	Sole	2024-02-12
2023-09-30	$4,167,300	290,000	+58.5%	Shares	Sole	2023-11-09
2023-06-30	$3,484,320	183,000	—	Shares	Sole	2023-08-07
No filing history on record for this holder in this stock.